Advertisement

Pharmacy

Home Pharmacy
Among adults with diagnosed diabetes

CDC Finds Vaccination Coverage Varies for Adults With Diabetes

Influenza vaccination coverage more prevalent than pneumococcal or hepatitis B vaccination
One in six U.S. adults take a psychiatric medication to treat conditions such as depression

Rate of Psychiatric Drug Use About 16 Percent in U.S. Adults

Highest rate of use seen for antidepressants
Administration of cytotoxic T-cells targeting mutant KRAS G12D can induce tumor regression in metastatic colorectal cancer

Cytotoxic T-Cells Can Induce Metastatic CRC Regression

Regression of tumors reported after administration of cytotoxic T-cells targeting mutant KRAS G12D
In women with advanced hormone receptor-positive

SABCS: Rx Combo Promising in Advanced HR+, HER2− Breast CA

Everolimus added to fulvestrant appears to improve progression-free survival
Some high-risk women who take tamoxifen to prevent breast cancer may mistake naturally occurring nausea and vomiting for side effects of the drug and stop taking it

SABCS: Tamoxifen May Be Unfairly Blamed for Side Effects

Perceived side effects might lead some to stop taking the medication, researchers say
Women taking aromatase inhibitors may show signs of early endothelial dysfunction that could lead to cardiovascular disease

SABCS: Aromatase Inhibitors Tied to Reduced Endothelial Function

Women on aromatase inhibitors exhibit less elasticity in their blood vessels
Cooling the scalp with a specialized cap during chemotherapy sessions could help breast cancer patients avoid treatment-related hair loss

SABCS: Scalp-Cooling System Can Reduce Chemo-Related Hair Loss

Devices reduce blood flow to hair follicles during chemotherapy treatments
An artificially intelligent computer system

SABCS: Artificial Intelligence May Aid Doctors in Breast Cancer Care

'Watson Oncology' agreed with doctors 90 percent of the time in many cases, researchers find
For hospitalized patients

Sleep Duration, Efficiency Linked to Inpatient Hyperglycemia

Longer sleep duration, increased sleep efficiency cut odds of hyperglycemia, impaired fasting glucose
Osimertinib is more effective than platinum-pemetrexed therapy in patients with T790M-positive advanced non-small-cell lung cancer whose disease has progressed during first-line epidermal growth factor receptor tyrosine kinase inhibitor treatment

Osimertinib Bests Platinum-Pemetrexed in T790M+ NSCLC

Significantly longer duration of progression-free survival with osimertinib vs platinum-pemetrexed